about
Seminal Fluid-Mediated Inflammation in Physiology and Pathology of the Female Reproductive TractResearch perspective: potential role of nitazoxanide in ovarian cancer treatment. Old drug, new purpose?Obesity, weight gain, and ovarian cancer risk in African American women.Interleukin 16- (IL-16-) Targeted Ultrasound Imaging Agent Improves Detection of Ovarian Tumors in Laying Hens, a Preclinical Model of Spontaneous Ovarian Cancer.Is ovarian cancer a targetable disease? A systematic review and meta-analysis and genomic data investigationAugmented Serum Amyloid A1/2 Mediated by TNF-induced NF-κB in Human Serous Ovarian Epithelial Tumors.Glucocorticoid-induced reversal of interleukin-1β-stimulated inflammatory gene expression in human oviductal cells.Variability in CRP, regulatory T cells and effector T cells over time in gynaecological cancer patients: a study of potential oscillatory behaviour and correlationsMetformin against cancer stem cells through the modulation of energy metabolism: special considerations on ovarian cancer.Mannose-Binding Lectin (MBL) and MBL-associated serine protease-2 (MASP-2) in women with malignant and benign ovarian tumoursUrinary interleukin-1β levels among gynecological patients.Aspirin Blocks EGF-stimulated Cell Viability in a COX-1 Dependent Manner in Ovarian Cancer CellsMinocycline suppresses interleukine-6, its receptor system and signaling pathways and impairs migration, invasion and adhesion capacity of ovarian cancer cells: in vitro and in vivo studies.Early inflammatory response in epithelial ovarian tumor cyst fluids.Interleukin 6 receptor is an independent prognostic factor and a potential therapeutic target of ovarian cancer.CXCR2-driven ovarian cancer progression involves upregulation of proinflammatory chemokines by potentiating NF-κB activation via EGFR-transactivated Akt signalingAssessment of selected cytokines, proteins, and growth factors in the peritoneal fluid of patients with ovarian cancer and benign gynecological conditions.Contraceptive methods and ovarian cancer risk among Chinese women: A report from the Shanghai Women's Health Study.Metformin prevents aggressive ovarian cancer growth driven by high-energy diet: similarity with calorie restriction.Ubiquitin E3 ligase MARCH7 promotes ovarian tumor growthUse of common analgesics is not associated with ovarian cancer survival.BRCA1 185delAG Mutation Enhances Interleukin-1β Expression in Ovarian Surface Epithelial Cells.AID/APOBEC-network reconstruction identifies pathways associated with survival in ovarian cancer.NF-κB-Mediated CCL20 Reigns Dominantly in CXCR2-Driven Ovarian Cancer Progression.Expression of Toll-like receptor 4 in ovarian serous adenocarcinoma and correlation with clinical stage and pathological gradeAdvantages of the avian model for human ovarian cancerLeptin stimulates migration and invasion and maintains cancer stem-like properties in ovarian cancer cells: an explanation for poor outcomes in obese womenThe Role of Cathelicidin LL-37 in Cancer Development.Effects of different electroacupuncture scheduling regimens on murine bone tumor-induced hyperalgesia: sex differences and role of inflammation.Inhibition of focal adhesion kinase (FAK) activity prevents anchorage-independent ovarian carcinoma cell growth and tumor progression.Characteristics of chemokine signatures elicited by EGF and TNF in ovarian cancer cells.Everolimus exhibits anti-tumorigenic activity in obesity-induced ovarian cancer.CCL18 from ascites promotes ovarian cancer cell migration through proline-rich tyrosine kinase 2 signalingThe inflammatory microenvironment in epithelial ovarian cancer: a role for TLR4 and MyD88 and related proteinsNSAID-activated gene 1 mediates pro-inflammatory signaling activation and paclitaxel chemoresistance in type I human epithelial ovarian cancer stem-like cells.Serum and peritoneal fluid concentrations of soluble human leukocyte antigen, tumor necrosis factor alpha and interleukin 10 in patients with selected ovarian pathologies.Targeting CSCs within the tumor microenvironment for cancer therapy: a potential role of mesenchymal stem cells.Current pharmacotherapy options for cancer anorexia and cachexia.Oncogene and non-oncogene addiction in inflammation-associated cancers.The role of interleukin-6 in the evolution of ovarian cancer: clinical and prognostic implications--a review.
P2860
Q26742070-9CDEDB1F-97BB-402B-9003-066D14F1E4C0Q28301465-13FFF422-37EF-45EC-8ED9-61AA36C3CC09Q30277051-2DFF76B8-2244-44D0-809F-53BCC5D870CEQ30407103-ABB93415-E085-40FF-90AB-E7CDC0695CE2Q31138109-4B28B6B5-3BCB-4A9E-912C-F5594CE7AE2AQ33611319-BB2043F0-ED3F-4FEE-ABDD-EE67A2D2C250Q33645478-67D06AE7-8FE2-431E-A37F-6E66EEACCB7DQ33848273-871344D8-328D-4103-8156-76539F8A2C69Q33890763-8CE8D0F0-3E4D-48E9-9F86-BD8525825438Q34402462-506D9FA1-5964-4DE8-91DB-0FDA3494BA7EQ34584672-F02BD644-1E8C-4716-B1BC-5F521DD91F8FQ34656901-CADEE54C-5A73-4639-8AE6-087BE7381807Q34674172-0EC87430-D878-4801-A61E-214CEC76C087Q34998539-C24910E7-D92F-4D5D-B16D-45E38C6EF6DCQ35058009-9D3F2A54-53B0-409D-8D66-0BA08CA1CD41Q35078196-0ABC7F44-5D49-4FA1-A7C4-BF6C1FB61C77Q35142408-A26B9F61-D2D2-4D4C-B1BD-93C2739214B0Q35624957-B9BB8B1F-27F5-4F77-9E5B-6BDD047C8484Q35793665-C37A4C85-C256-49CC-A3C4-7A9EB4F30803Q35828527-10742127-9D4C-4454-B8A4-AB46CCCBFB27Q35920931-9C701228-CD40-41D0-AD8A-74F15A0B93B3Q36017531-96B8B007-7D3D-439D-8C63-57C4FDBF5F3EQ36104522-8473FC95-0005-49FD-9693-745E10343B6CQ36159383-D22734BA-4B3F-4830-9BA9-5B813586AD79Q36183623-3DA4C05F-56F4-490A-8626-6E4A4BE9E17EQ36334681-58CF3EAA-59B1-48B2-887C-C65CF5E3CEC5Q36356253-32E2F098-32BE-4D29-8274-33516965FF9AQ36465085-26BF28F8-A886-4BB0-99F6-CFEA7BBBAB5CQ36522438-8D23CFCB-0D52-4670-BF0F-C3DDF4E4B9CCQ36754457-A8E4E03A-B47F-42C0-ACBE-0DA87FFD528EQ36960019-B3427BC3-7047-44C4-BFB7-1DCE01ADF3C2Q37190310-AD263E45-D7ED-4725-BC7E-02BB3A2F9484Q37244183-46EC224A-10FF-4AA9-9581-AAFF78E74423Q37396607-77CE5EB6-BF26-4C30-85DF-07DCCBD666CBQ37687793-567E7AC7-CB51-4078-96F9-45635D4CE03EQ37738040-D672ABE4-19F0-493C-89C8-06963C5892A0Q38033243-52F784C3-FF20-4D5C-A8EB-39B6C9D8A3DCQ38052613-C9C6D73A-A552-499A-8889-C0308AA7F91EQ38096415-3C3D52AC-16AC-4D7C-AD29-85061FDCA370Q38140767-631CFE5E-B37E-4DD5-85A9-0A7671C0F29E
P2860
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Inflammation and ovarian cancer.
@en
Inflammation and ovarian cancer.
@nl
type
label
Inflammation and ovarian cancer.
@en
Inflammation and ovarian cancer.
@nl
prefLabel
Inflammation and ovarian cancer.
@en
Inflammation and ovarian cancer.
@nl
P1433
P1476
Inflammation and ovarian cancer.
@en
P2093
Antonio Macciò
Clelia Madeddu
P304
P356
10.1016/J.CYTO.2012.01.015
P577
2012-02-19T00:00:00Z